Development Program Funding Clause Samples
Development Program Funding. AZ shall reimburse ABX for the fees and expenses incurred by ABX in performing its activities under each Development Program or pursuant to Section 5.13.2, provided that such fees and expenses are determined pursuant to Section 5.3 and do not exceed the amounts set forth in the applicable Program Budget for the relevant activities without the approval of AZ (the “Authorized Development Expenses”); and provided further that if ABX uses, subject to Section 5.2.2, a Third Party contract research organization to perform any of its activities under such Development Program any fees charged by such Third Party or any other external costs incurred by or on behalf of ABX shall be passed through to AZ without any ▇▇▇▇-up by ABX. ABX shall invoice AZ for its Authorized Development Expenses incurred during each calendar month, which invoice shall be accompanied by expense reports and such other supporting documentation as may be requested by AZ. AZ shall pay each such invoice within [Confidential treatment requested] after the date of receipt of such invoice and supporting documentation.
Development Program Funding. Except as otherwise expressly provided herein or as otherwise expressly agreed by the Parties in writing, Alfacell shall be solely responsible for payment of all Development Costs.
Development Program Funding. As consideration for, and to partially fund the costs to be incurred by EXEL for, the research activities to be conducted by EXEL for the intended benefit of GSK pursuant to the Development Program, GSK shall pay the following research and development payments (collectively, the “Research and Development Payments”):
Development Program Funding. Par shall make the payments for Development Costs in accordance with Section B.10 of Exhibit B. If in any calendar year Advancis anticipates a Development Funding Gap or there is a Development Funding Gap, within its sole discretion, Advancis shall have the right (a) to continue to incur and self-fund the Development Costs for such calendar year and/or (b) to procure third party funding of such shortfall and/or (c) to modify or delay the Development Plan in order to adjust the amount or timing of funds needed thereunder to match the payments being made by Par pursuant to Exhibit B. Provided that Advancis shall [***] to notify Par quarterly of the Development Costs incurred by Advancis in accordance with this Agreement as they are incurred during Term; nothing herein shall restrict Advancis’s right to reasonably delay or withhold its invoicing of Development Costs incurred under this Agreement pursuant to the foregoing items (a), (b) and (c) of this Section 4.4. Any delay in the Development Plan pursuant to this Section 4.4 [***] by Advancis. To the extent that there is a Development Funding Gap, such Development Funding Gap shall be reimbursed to Advancis out of Par’s share of Operating Profits in accordance with Exhibit B.
Development Program Funding. In consideration of Tevard’s performance of its obligations under the Development Plan for each Development Program upon the terms and conditions contained herein, Zogenix shall pay Tevard the Development Costs as set forth in Section 2.1.5 and this Section 2.1.6 and in accordance with the applicable Budget.
(a) At least ten (10) days prior to the start of any Calendar Quarter, and subject to receipt of a corresponding invoice from Tevard, Zogenix will pay Tevard the estimated amount set forth in the Budget for the corresponding Calendar Quarter (each such quarterly payment is referred to herein as an “Estimated Pre-Payment”).
(b) Starting with the first Calendar Year following the Effective Date and within thirty (30) days after (i) the end of each Calendar Year during the Research Term and (ii) the date of termination or ||| expiration of the Research Term, Tevard shall perform a true-up for all FTE Costs and Out-of-Pocket Expenses actually incurred during the applicable Calendar Year (or partial Calendar Year in the event of termination or expiration) with respect to which Estimated Pre-Payments have been paid by Zogenix to reconcile the FTE Costs and Out-of-Pocket Expenses that were actually incurred during such Calendar Year (or partial Calendar Year) with the Development Costs that were paid by Zogenix with respect thereto. The true-up for the first full Calendar Year following the Effective Date shall include the Calendar Quarter of the previous year. Tevard shall provide to Zogenix its cost accounting documentation and other information reasonably requested by Zogenix to document the reconciliation.
(c) Each Party shall make reconciling payments to the other as necessary to effect such true-up with respect to the FTE Costs and Out-of-Pocket Expenses for such Calendar Year (or partial Calendar Year). If Zogenix is required to make a payment to Tevard to effect such reconciliation, then Zogenix shall provide such payment to Tevard within twenty-one (21) days of the determination of such payment. If Tevard is required to make a payment to Zogenix to effect such reconciliation, Tevard shall offset such amount against future amounts owed by Zogenix to Tevard pursuant to this Section 2.1.6. If either Party is required to make a payment to effect such reconciliation following the expiration or termination of the Research Program Term, such Party shall make such payment directly to the other Party within thirty (30) days following receipt of the reconcilia...
Development Program Funding. 3.5.1 The Work Plan and Budget as of the Effective Date is attached hereto as Attachment B and describes CRI’s, CHOP’s and TGC’s respective work for the current Project Year of the Development Program. On or before the end of the ninth month of each Project Year, CRI, CHOP and TGC will jointly prepare and provide in draft form to IAVI a proposed Work Plan and Budget for the next Project Year, containing a statement of CRI’s, CHOP’s and TGC’s work for next Project Year and of the amounts of budgeted Collaboration Payments to be made with respect to that Project Year. CHOP, IAVI and TGC (and CRI with respect to any part of the Work Plan and Budget that assigns any Development Work to CRI) will work in good faith to agree on the final, written Work Plan and Budget for the next Project Year on or before the end of the eleventh month of each Project Year. All Work Plan and Budgets will take into account the progress made to that time in the course of the Development Program, and none of CHOP, IAVI or TGC (nor CRI with respect to any part of the Work Plan and Budget that assigns any Development Work to CRI) will unreasonably withhold or delay its agreement to any such Work Plan and Budget.
3.5.2 IAVI agrees to pay CRI, CHOP and/or TGC the quarterly Collaboration Payments set forth in the applicable Work Plan and Budget. [*] of the Collaboration Payments due and payable for a Program Quarter, estimated based on the applicable Work Plan and Budget, will be paid by IAVI to CRI, CHOP and TGC on or before the first day of such Program Quarter. The remainder of the Collaboration Payments for such Program Quarter will be due and payable within thirty (30) days of receipt of each respective invoice from CRI, CHOP and TGC for the actual services rendered or any costs incurred by each of CRI, CHOP and TGC (net of the Collaboration Payments already made for such Program Quarter) with respect to the concluded Program Quarter, which invoice must be accompanied by an activity-based expenditure report in such form as may be reasonably acceptable to IAVI. Each such invoice will be paid by IAVI to CRI, CHOP and TGC respectively (and each invoice shall be separately payable regardless of whether or not any other invoice has been properly submitted). If, during any Project Year, the Program Management Committee (and CRI, if Sections 3.2.3 or 3.2.6 apply) recommends and IAVI agrees to modify or otherwise change the activities to be conducted by CRI, CHOP or TGC, or the amount budge...
Development Program Funding. Monies contributed by the Parties to fund the Development Program shall be expended by the Parties in accordance with the Development Plan and Budget.
Development Program Funding. If BioAlliance determines to pursue any clinical development in respect of the Product following Regulatory Approval, including any development for PCP prophylaxis or any other PCP indication, the development costs in respect thereof shall be the responsibility of BioAlliance, subject to the royalty reduction for such costs provided in Section 3.3(b).
Development Program Funding. In consideration for Nastech's performance of its obligations under the Development Program (which shall not include Nastech's obligations under the Supply Agreement or Nastech's obligations to supply Clinical Supplies in accordance with Section 3.6), upon the terms and conditions contained herein, Merck shall reimburse Nastech for expenses it has actually incurred in the performance of such activities and as previously approved by the PDT or Merck in accordance with Section 2.5, but only to the extent such amounts are set forth in the development budget as determined in accordance with Section 2.4. Reimbursements by Merck under the foregoing shall be payable as stated in Section 2.5.2.
Development Program Funding. Immtech shall be solely responsible for payment of all Development Costs incurred prior to Regulatory Approval. If Par determines to pursue any clinical development in respect of the Product following Regulatory Approval, including any development for PCP prophylaxis or any other PCP indication, the development costs in respect thereof shall be the responsibility of Par unless the Parties otherwise agree.